A retrospective multicenter study on the efficacy and safety of disitamab vedotin monotherapy versus combination with anti-PD-1 immunotherapy in advanced gastric cancer

S Shuailei Dong C Chen Wei (Department of Mechanical and Aerospace Engineering, University of California Los Angeles) X Xueting Wang X Xinyi Yang (School of Materials Science and Engineering, Tianjin University, Tianjin, China.) W Wei Shen S Shuyi Li (Laboratory of Controllable Nanopharmaceuticals, Chinese Academy of Sciences Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Chinese Academy of Sciences Center for Excellence in Nanoscience, National Center for Nanoscience and Technology) J Jiye Xu Y Yijie Ma L Liangyu Bie W Wenyue Yu N Ning Li

Article Details

Volume / Issue Vol. 15, Issue 1
Published January 17, 2025
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (11)

S

Shuailei Dong

C

Chen Wei

Department of Mechanical and Aerospace Engineering, University of California Los Angeles

X

Xueting Wang

X

Xinyi Yang

School of Materials Science and Engineering, Tianjin University, Tianjin, China.

W

Wei Shen

S

Shuyi Li

Laboratory of Controllable Nanopharmaceuticals, Chinese Academy of Sciences Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Chinese Academy of Sciences Center for Excellence in Nanoscience, National Center for Nanoscience and Technology

J

Jiye Xu

Y

Yijie Ma

L

Liangyu Bie

W

Wenyue Yu

N

Ning Li